Searched for
NOVARTIS SHARES
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equity markets extended losses for a fourth straight session as broad-based selling in IT, banking, auto, and consumer stocks dragge...
- Global Markets | European shares subdued as US-Iran talks stall; corporate earnings on tapEuropean shares were muted on Tuesday as investors braced for a week packed with central bank meetings and corporate earnings, while weighi...
- ChrysCapital, two others launch open offer for Novartis IndiaA consortium including WaveRise Investments, ChrysCapital, and Two Infinity Partners is set to acquire a significant stake in Novartis Indi...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- Novartis puts its India-listed entity for up for saleThe strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assu...
- Novartis launches new share buyback of up to $15 blnThe Swiss pharma company confirmed it expected sales to grow by 4% or more through 2026. Its capital allocation strategy aims to combine in...
- Novartis India posts Q4 net at Rs 2.91 croreStandalone total income of the company stood at Rs 160.30 crore for the quarter under consideration. It was Rs 187.19 crore for the same pe...
- Novartis shares up nearly 2% at closeShares of Novartis India ended nearly 2% higher after fair trade regulator CCI approved a multi-billion dollar deal between GlaxoSmithKline...
- Novartis appoints Citigroup as broker for Indian unit share saleDrug major Novartis India said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share ...
- Alembic Pharmaceuticals soars on patent settlement case with NovartisShares of Alembic Pharma surged by over 4% after the co said it along with Breckenridge Pharma Inc, USA has settled a patent case with Nova...
- Novartis concludes acquisition of 77% Alcon stake from NestleNovartis on Thursday said it has concluded a $28.3 billion deal with Alcon Inc that will give the Swiss drug-maker a controlling stake in t...
- Novartis looks to buy out Alcon for $38.5 bnDrug maker Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake.
- FIs respond to Novartis’ open offerInstitutional shareholders have participated in a big way in Novartis AG’s open offer for its Indian subsidiary Novartis India, boosting th...
- Novartis soars 20 pc as Swiss parent sweetens offer priceSwiss drug firm Novartis AG sweetened its open offer price to Rs 450 a share for acquiring an additional 39 per cent stake in its Indian su...
- Novartis open offer for Indian arm to begin on May 20Swiss Drug maker Novartis AG's open offer for acquiring an additional 39 pr cent stake in its Indian subsidiary will begin on May 20.
- Novartis' open offer hangs in balanceThe fate of the open offer of Swiss pharma giant Novartis to scale up its stake in its Indian subsidiary Novartis India looks uncertain wit...
- Novartis open offer for Indian arm to begin on May 14Swiss drug maker Novartis AG's open offer for acquiring an additional 39 per cent stake in its Indian subsidiary will begin on May 14.
Load More
